Clinical Trials Directory

Trials / Completed

CompletedNCT00996190

Best Regimen for Phenylephrine Administration During Cesarean Section

Study to Determine the Best Regimen for Administration of Phenylephrine During Spinal Anesthesia for Cesarean Delivery, as Determined by Maternal Blood Pressure and Cardiac Output

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Samuel Lunenfeld Research Institute, Mount Sinai Hospital · Academic / Other
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

During Cesarean delivery, phenylephrine is used to maintain the patient's blood pressure. Low blood pressure is the most common side effect of the spinal medication used to anesthetize the patient prior to the start of surgery. This low blood pressure can also trigger unpleasant side effects such as nausea, vomiting and low Apgar scores for the baby. Currently there are 2 methods of phenylephrine administration during Cesarean section. One method is by intermittent bolus and the other is by continuous infusion. It is ideal to have a regimen for phenylephrine administration that maintains blood pressure without compromising cardiac output. In this study, cardiac output and blood pressure will be measured by transthoracic bioimpedance, which is a new technique of noninvasive continuous cardiac output monitoring. The hypothesis of this study is that the continuous infusion of phenylephrine will be equally effective in maintaining blood pressure as compared to the intermittent injection, and will induce less hemodynamic changes.

Conditions

Interventions

TypeNameDescription
DRUGPhenylephrinephenylephrine 120 micrograms/mL, administered either by continuous infusion or by intermittent bolus dose

Timeline

Start date
2009-11-01
Primary completion
2010-08-01
Completion
2010-08-01
First posted
2009-10-16
Last updated
2011-02-23

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00996190. Inclusion in this directory is not an endorsement.